Estimated Budget Impact Of Cholesterol Decreasing In The Russian Population

Abstract

USD, representing the 0.02536% of the budget of the NHS. The deterministic sensitivity analysis confirm that the results were robust. ConCluSionS: According to the results of the BIA, the inclusion of bosentan to the NHS of Mexico is displayed as an affordable option for the treatment of pediatric patients (2-12 years) with HAP.